TY  - GEN
AU  - Wu,Chih-Hsun
AU  - Hwang,Ming-Jing
TI  - Risk stratification for lung adenocarcinoma on EGFR and TP53 mutation status, chemotherapy, and PD-L1 immunotherapy
SN  - 2045-7634
PY  - 2020///0914
KW  - Adenocarcinoma of Lung
KW  - drug therapy
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - B7-H1 Antigen
KW  - antagonists & inhibitors
KW  - ErbB Receptors
KW  - genetics
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Immunotherapy
KW  - Lung Neoplasms
KW  - Mutation
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Risk Assessment
KW  - Survival Analysis
KW  - Tumor Suppressor Protein p53
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/cam4.2492
ER  -